Forte Biosciences (FBRX) Proxy Filing summary

Executive summary

• The 2025 Annual Meeting will be held virtually on May 29, 2025, with voting available online, by phone, or mail.

• Stockholders will vote on electing three Class II directors and ratifying KPMG LLP as the independent auditor for 2025.

• Only stockholders of record as of April 30, 2025, are entitled to vote; each share has one vote per matter.

• Proxy materials and the annual report are accessible online and by mail.

Voting matters and shareholder proposals

• Proposals include electing Richard Vincent, Shiv Kapoor, and David Gryska as Class II directors and ratifying KPMG LLP as auditor.

• Board recommends voting FOR all nominees and auditor ratification.

• Shareholder proposals for the 2026 meeting must be submitted by December 31, 2025, for proxy inclusion.

• Advance notice is required for other proposals or director nominations, with specific timing and information requirements.

Board of directors and corporate governance

• Board consists of eight directors, six of whom are independent; directors serve staggered three-year terms.

• Committees include audit, compensation, and nominating/corporate governance, all with independent members.

• Board leadership combines CEO and chairman roles; no lead independent director currently appointed.

• Board and committees oversee risk, compliance, and governance practices.

• Policies prohibit hedging, pledging, and certain trading of company securities by insiders.